Firmoscan
Active09376285Private limited companyMaidenhead

CONVERGENCE PHARMACEUTICALS LIMITED

Significant control: Biogen Inc. (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Convergence Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Convergence Pharmaceuticals Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

CONVERGENCE PHARMACEUTICALS LIMITED is an active private limited company (company number 09376285) incorporated on 6 January 2015, registered in Maidenhead. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (small) but not yet parsed into this record.

There are 50 companies in research and experimental development on biotechnology in Reading with filed accounts; the median reports net assets of £11k and is 7 years old.

02

Ownership and control

1 active
  • Biogen Inc.
    corporate entity, Delaware · since 6 April 2016
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
6 January 201511 yrs ago
First accounts due
6 October 20163671 days overdue
Confirmation statement due
20 January 2027in 87 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Small
05

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

06

Filing and accounts signals

Facts from the register · no rating
  • Incorporated five or more years agoIncorporated 6 January 2015
  • Accounts past their due dateDue 6 October 2016

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 87 days
  2. First accounts due3671 days overdue
  3. Incorporated
08

Similar companies in Reading

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 6 January 2015 · in Jan 2015.

09

Reminders for CONVERGENCE PHARMACEUTICALS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.

This information comes from public filings and our automated processing of them. It may contain errors, be incomplete or be out of date, and is not advice or a credit reference. Check the official record before relying on it. Terms · Privacy · Report an error (corrected within one working day).